Discover

DVA
DaVita Inc.
181.55
300 x 174.25
300 x 184.00
bid
ask
+
0.22
0.12%
300 @ 05:05 PM
181.55 +0.00 (0.00%)
Ytd59.80%
1y36.26%
180.96
day range
183.90
103.87
52 week range
240.96
Open181.24Prev Close181.33Low180.96High183.90Mkt Cap11.58B
Vol767.85KAvg Vol826.90KEPS11.80P/E15.39Forward P/E10.52
Beta0.83Short Ratio4.72Inst. Own48.39%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning10-2850-d Avg205.99200-d Avg165.071yr Est218.43
Earning
DateForEstimateReportedSurprisesurprise %
2026-10-282026-093.58N/AN/AN/A
2026-08-042026-063.884.020.143.61%
2026-05-052026-032.412.870.4619.09%
2026-02-022025-123.243.40.164.94%
2025-10-292025-093.172.51-0.66-20.82%
2025-08-052025-062.72.950.259.26%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-07TD CowenUpgradeHoldBuy
2026-08-07Truist SecuritiesUpgradeHoldHold
2026-08-05BarclaysUpgradeEqual-WeightEqual-Weight
2026-07-14Truist SecuritiesUpgradeHoldHold
2026-07-10UBSUpgradeBuyBuy
2026-07-09BarclaysUpgradeEqual-WeightEqual-Weight
Profile
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Insider Holder
DateNameRelationQuantityDescription
2026-05-06ACKERMAN JOELChief Financial Officer132.43KSale
2026-08-13ARWAY PAMELA M.Director27.22KStock Award(Grant)
2025-05-14BERG CHARLES GDirector27.03KStock Award(Grant)
2026-07-30BERKSHIRE HATHAWAY, INC.Beneficial Owner of more than 10% of a Class of Security0.00Sale
2026-03-12BERRY CHRISTOPHER MICHAELOfficer19.64KStock Award(Grant)
2026-08-13DESOER BARBARA JDirector14.30KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Berkshire Hathaway, Inc28.88M5.24B45.27%
2026-06-29Blackrock Inc.2.46M446.62M3.86%
2026-06-29Vanguard Capital Management LLC2.10M381.37M3.29%
2026-06-29Morgan Stanley1.60M290.68M2.51%
2026-06-29Vanguard Portfolio Management LLC1.38M250.06M2.16%
2026-06-29State Street Corporation1.32M240.10M2.07%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.02M184.98M1.60%
2026-07-30Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF938.67K170.35M1.47%
2026-06-29VANGUARD INDEX FUNDS-Vanguard 500 Index Fund830.14K150.65M1.30%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund736.44K133.65M1.15%
2026-07-30NEUBERGER BERMAN EQUITY FUNDS-Neuberger Quality Equity Fund675.08K122.51M1.06%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund466.34K84.63M0.73%
Split
SplitDate
2 : 12013-09-09
1.5 : 12004-06-16
5 : 31997-10-21